Timor-Leste Vaccine Support

Australia has committed $24.3 million for COVID-19 vaccine access during 2020-23 in Timor-Leste.

  • 1,190,040 vaccine doses delivered to date
  • Vaccines from Australia’s supply
  • Vaccines procured through Australia’s UNICEF Partnership


Supporting National Vaccine Rollout
  • Cold chain and supply chain management
  • Advocacy and demand generation
  • Identifying target populations
  • Monitoring and evaluation


Providing Technical Expertise
  • Strengthening systems to ensure vaccine safety
  • Using evidence to build quality immunisation programs


Our Impact So Far

  • An Australian public health physician has been deployed to support the Timorese Ministry of Health to plan and implement its COVID-19 vaccination program.
  • The Therapeutic Goods Administration (TGA) worked with regulators in Timor-Leste to assess AstraZeneca vaccines supplied by Australia to support approval for local use.
  • Experts from the TGA and the National Centre for Immunisation Research and Surveillance (NCIRS) partnered to provide advice to Timor-Leste health officials and clinicians on the benefits and risks of using the AstraZeneca vaccine, including specific advice from NCIRS on adverse events following vaccination.

Photo: Amelia and Maricana showing vaccination certificates. Credit: DFAT.

Sarah Sheridan and Joshua Francis at NITAG, Timor-Leste

Australian expert supports Timor-Leste rollout

Australia is working with the Timor-Leste Ministry of Health (MoH) to support COVID-19 vaccine roll out plans.
COVID-19 vaccine batch testing at the TGA

Australian regulator puts COVID-19 vaccine to the test

Australia has shared millions of COVID-19 vaccines with our neighbours. Each vaccine batch has passed an independent ‘batch release assessment’ to confirm consistent safety, efficacy and quality.